{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:28:44Z","timestamp":1759091324956},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hungarian Scientific Research Found","award":["OTKA F048380","T81624","T84262"],"award-info":[{"award-number":["OTKA F048380","T81624","T84262"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.cyto.2015.02.024","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:35:23Z","timestamp":1426638923000},"page":"219-224","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas"],"prefix":"10.1016","volume":"73","author":[{"given":"Anna","family":"Sebesty\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"M\u00e1rk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Hajdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mi","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"V\u00e9gs\u0151","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Barna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.02.024_b0005","first-page":"154","article-title":"B-cell antigen receptor competence regulate selection and survival","volume":"176","author":"Buhl","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2015.02.024_b0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cyto.2015.02.024_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"MTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2015.02.024_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157489210789702208","article-title":"Inhibitors of the PI3K\/Akt\/mTOR pathway: new hope for breast cancer patients","volume":"5","author":"Ghayad","year":"2010","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.cyto.2015.02.024_b0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/erm.09.8","article-title":"MTOR in renal cell cancer: modulator of tumor biology and therapeutic target","volume":"9","author":"Wysocki","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cyto.2015.02.024_b0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1634\/theoncologist.2010-0318","article-title":"Utility of mTOR inhibition in hematologic malignancies","volume":"16","author":"Younes","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.cyto.2015.02.024_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","article-title":"Dissecting the role of mTOR: lessons from mTOR inhibitors","volume":"1804","author":"Dowling","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cyto.2015.02.024_b0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/CCO.0000000000000010","article-title":"Recent advances in the management of mantle cell lymphoma","volume":"25","author":"Rivera-Rodriguez","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cyto.2015.02.024_b0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2217\/fon.13.113","article-title":"Signaling pathways in lymphoma: pathogenesis and therapeutic targets","volume":"9","author":"Arita","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/j.cyto.2015.02.024_b0205","article-title":"Developing novel strategies to target B-cell malignancies","volume":"33","author":"Fowler","year":"2013"},{"key":"10.1016\/j.cyto.2015.02.024_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2015.02.024_b0060","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","article-title":"Role of transforming growth factor-beta in hematologic malignancies","volume":"107","author":"Dong","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.02.024_b0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.2785","article-title":"The dynamic roles of TGF-\u03b2 in cancer","volume":"223","author":"Meulmeester","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.cyto.2015.02.024_b0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2005.01.013","article-title":"Smad signal and TGFbeta induced apoptosis in human lymphoma cells","volume":"30","author":"Sebesty\u00e9n","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2015.02.024_b0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20100427","article-title":"Regulation of TGF-beta signalling by protein phosphatases","volume":"430","author":"Liu","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.cyto.2015.02.024_b0085","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.yexcr.2007.05.028","article-title":"Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells","volume":"313","author":"Sebesty\u00e9n","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0090","first-page":"1207","article-title":"TGF\u03b21 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells","volume":"21","author":"T\u00f3tth","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.emboj.7600917","article-title":"Novel roles of Akt and mTOR in suppressing TGF-beta\/ALK5-mediated Smad3 activation","volume":"25","author":"Song","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2015.02.024_b0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200611146","article-title":"Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway","volume":"178","author":"Lamouille","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cyto.2015.02.024_b0105","first-page":"1645","article-title":"New in vitro line from a human (B) non-Hodgkin lymphoma","volume":"11","author":"Kopper","year":"1991","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF02893956","article-title":"Detection of drug-induced apoptosis by flow cytometry after alkaline extraction of ethanol fixed cells","volume":"2","author":"Mihalik","year":"1996","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0115","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.leukres.2006.12.019","article-title":"Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas","volume":"31","author":"V\u00e9gs\u0151","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2407-13-250","article-title":"Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease\u2013a combined tissue microarray, in vitro and in vivo study","volume":"13","author":"M\u00e1rk","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2015.02.024_b0125","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.0312167","article-title":"All-trans retinoic acid and rapamycin synergize with transforming growth factor-b1 to induce regulatory T cells but confer different migratory capacities","author":"Jhunjhunwala","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2015.02.024_b0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibs.2013.10.001","article-title":"Signaling interplay between transforming growth factor-b receptor and PI3K\/Akt pathways in cancer","volume":"38","author":"Zhang","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cyto.2015.02.024_b0135","article-title":"TGF-b\/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1a expression","volume":"305","author":"Rozen","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cyto.2015.02.024_b0140","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1172\/JCI65859","article-title":"Reciprocal regulation by TLR4 and TGF-b in tumor infiltrating stem-like cells","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.024_b0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2741\/1095","article-title":"The immunophilin FKBP12: a molecular guardian of the TGF-beta family type I receptors","volume":"9","author":"Wang","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/j.cyto.2015.02.024_b0150","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10495-007-0085-5","article-title":"Prevention of TGF-beta-induced apoptosis by interleukin-4 through Akt activation and p70S6K survival signaling pathways","volume":"12","author":"Lin","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.cyto.2015.02.024_b0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","article-title":"MTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation","volume":"30","author":"Hong","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.cyto.2015.02.024_b0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cyto.2015.02.024_b0165","doi-asserted-by":"crossref","first-page":"37909","DOI":"10.1074\/jbc.M109.093724","article-title":"TGF-beta1 protects against mesangial cell apoptosis via induction of autophagy","volume":"285","author":"Ding","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.024_b0170","first-page":"143","article-title":"Apoptosis and autophagy induced by TGF-\u03b21 in bovine mammary epithelial BME-UV1 cells","volume":"56","author":"Gajewska","year":"2005","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.cyto.2015.02.024_b0175","doi-asserted-by":"crossref","first-page":"19179","DOI":"10.1074\/jbc.M513377200","article-title":"Autophagy contributes to caspase-independent macrophage cell death","volume":"281","author":"Xu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2015.02.024_b0180","first-page":"4179","article-title":"Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells","volume":"25","author":"Barna","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cyto.2015.02.024_b0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cyto.2015.02.024_b0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/bjh.13065","article-title":"Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma","volume":"167","author":"Blachly","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cyto.2015.02.024_b0195","doi-asserted-by":"crossref","first-page":"18856","DOI":"10.3390\/ijms151018856","article-title":"Computer-aided targeting of the PI3K\/Akt\/mTOR pathway: toxicity reduction and therapeutic opportunities","volume":"15","author":"Li","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cyto.2015.02.024_b0200","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/modpathol.2012.141","article-title":"Activity and complexes of mTOR in diffuse large B-cell lymphomas\u2014a tissue microarray study","volume":"25","author":"Sebesty\u00e9n","year":"2012","journal-title":"Mod Pathol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615001027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615001027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:20:25Z","timestamp":1537780825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1043466615001027"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.024","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}